We are pleased to announce the appointment of Dr Gabrielle Silver as Non-Executive Director of Voyage Care. A doctor by background, Gabrielle has worked in a number of global healthcare organisations. She is the Chief Executive Officer of Bioscript Group and a Director of Opiant Pharmaceuticals. Most recently she led CHS healthcare, a business focusing on supporting people as they transitioned from the health to social care sector. She has also served as a non-executive director at the Royal National Orthopaedic Hospital NHS Trust for the last 7 years. She has broad leadership experience in the healthcare sector across life sciences, medical technology, software development as well as healthcare services
Gabrielle Silver replaces Douglas Quinn.
Gabrielle Silver, Non-Executive Director said:
“I am excited to be joining the Board at Voyage Care and to be part of such a strong team with a clear organisational purpose. Their focus on quality of life outcomes for the people supported aligns with my passion for making a real difference in health and care. I look forward to working with the Voyage Care team to continue to develop their sector leading specialist provision.”
Andrew Cannon, Chief Executive of Voyage Care said:
“We are pleased to welcome Gabrielle to Voyage Care. Her clinical background and focus on improving the quality of life for those we support is consistent with our values and vision. As Voyage Care moves in the next phase of growth her extensive leadership experience will provide a vital contribution to the Board.”